An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.

TODAY i have some great news to share. Besides the fact that last week was the King's Birthday, something exciting was happening in the HIV ...

The European Medicines Agency has recommended the approval of lenacapavir, a new bi-annual injectable drug aimed at ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

What is lenacapavir and how does it work? Lenacapavir is a medicine used to help prevent and treat HIV. It works by blocking the outer shell, or “capsid,“ that the virus needs to protect itself.

“Lenacapavir helps to fill a critical unmet need for people with complex prior treatment histories and offers physicians a long-awaited twice-yearly option for these patients who are at greater ...

For lenacapavir, 100% efficacy for HIV prevention in women in PURPOSE 1 [NCT04994509], 96% [reduction in risk of HIV] in men and gender diverse people [in PURPOSE 2].

Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative to daily pills and addressing the needs of key populations.

What Is Lenacapavir? Lenacapavir by Yeztugo is an injectable HIV-1 capsid inhibitor to reduce the risk of HIV in adolescents and adults weighing at least 35 kg. It is a first-of-its-kind drug ...